Sofinnova Investments as of June 30, 2021
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 67 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera Comm (NTRA) | 20.3 | $352M | 3.1M | 113.53 | |
| Karuna Therapeutics Comm | 12.8 | $223M | 2.0M | 113.99 | |
| Aerovate Therapeutics Comm (AVTE) | 4.9 | $86M | 3.8M | 22.83 | |
| Y-mAbs Therapeutics Comm | 4.3 | $74M | 2.2M | 33.80 | |
| Ascendis Pharma A/S Adr (ASND) | 4.0 | $69M | 522k | 131.55 | |
| AstraZeneca Adr (AZN) | 3.3 | $58M | 960k | 59.90 | |
| iShares TR iShares Biotech Put Option | 3.1 | $53M | 325k | 163.65 | |
| Bolt Biotherapeutics Comm | 2.5 | $43M | 2.8M | 15.46 | |
| United Therapeutics Corp Comm (UTHR) | 2.2 | $39M | 216k | 179.41 | |
| Vera Therapeutics Cl A (VERA) | 2.2 | $39M | 2.9M | 13.26 | |
| Biogen Comm (BIIB) | 2.2 | $38M | 111k | 346.27 | |
| Inozyme Pharma Comm (INZY) | 2.0 | $35M | 2.0M | 17.04 | |
| Galera Therapeutics Comm (GRTX) | 1.7 | $30M | 3.1M | 9.83 | |
| Acceleron Pharma Comm | 1.7 | $29M | 234k | 125.49 | |
| Align Technology Comm (ALGN) | 1.7 | $29M | 47k | 611.00 | |
| PTC Therapeutics Comm (PTCT) | 1.4 | $25M | 582k | 42.27 | |
| Insmed Comm (INSM) | 1.4 | $24M | 844k | 28.46 | |
| Sarepta Therapeutics Comm (SRPT) | 1.3 | $23M | 299k | 77.74 | |
| Ark Etf Tr Genomic Rev ETF Put Option | 1.3 | $23M | 250k | 92.50 | |
| Heron Therapeutics Comm (HRTX) | 1.3 | $23M | 1.5M | 15.52 | |
| Checkmate Pharmaceuticals Comm | 1.2 | $22M | 3.6M | 5.96 | |
| Nextcure Comm (NXTC) | 1.2 | $22M | 2.7M | 8.03 | |
| Protagonist Therapeutics Comm (PTGX) | 1.2 | $20M | 449k | 44.88 | |
| Neurocrine Biosciences Comm (NBIX) | 1.1 | $20M | 203k | 97.32 | |
| Exelixis Comm (EXEL) | 1.1 | $20M | 1.1M | 18.22 | |
| Akouos Comm | 1.1 | $19M | 1.5M | 12.55 | |
| Insulet Corp Comm (PODD) | 1.1 | $19M | 69k | 274.51 | |
| Vertex Pharmaceuticals Comm (VRTX) | 1.0 | $18M | 88k | 201.63 | |
| Regenxbio Comm (RGNX) | 1.0 | $17M | 428k | 38.85 | |
| Nucana Biomed Adr | 0.9 | $16M | 5.6M | 2.77 | |
| Agenus Comm | 0.9 | $15M | 2.8M | 5.49 | |
| Dexcom Comm (DXCM) | 0.8 | $14M | 34k | 426.99 | |
| ObsEva SA Comm | 0.8 | $14M | 4.7M | 3.03 | |
| Intra-Cellular Therapies Comm (ITCI) | 0.7 | $13M | 313k | 40.82 | |
| Mirati Therapeutics Comm | 0.7 | $13M | 79k | 161.53 | |
| Agios Pharmaceuticals Comm (AGIO) | 0.7 | $12M | 219k | 55.11 | |
| Reata Pharmaceuticals Comm | 0.6 | $11M | 80k | 141.53 | |
| Uniqure NV Comm (QURE) | 0.6 | $10M | 324k | 30.80 | |
| Amgen Comm (AMGN) | 0.6 | $9.9M | 41k | 243.75 | |
| Cytokinetics Comm (CYTK) | 0.5 | $9.5M | 481k | 19.79 | |
| Kura Oncology Comm (KURA) | 0.5 | $9.3M | 444k | 20.85 | |
| Nucana Biomed Ordinary Shares | 0.4 | $6.6M | 2.4M | 2.77 | |
| MacroGenics Comm (MGNX) | 0.4 | $6.3M | 235k | 26.86 | |
| ChemoCentryx Comm | 0.4 | $6.2M | 466k | 13.39 | |
| Marinus Pharmaceuticals Comm | 0.4 | $6.2M | 346k | 17.94 | |
| Coherus BioSciences Comm (CHRS) | 0.3 | $6.0M | 435k | 13.83 | |
| Cyteir Therapeutics Comm | 0.3 | $5.7M | 265k | 21.40 | |
| FibroGen Comm Put Option | 0.3 | $5.3M | 200k | 26.63 | |
| Immatics NV Comm (IMTX) | 0.3 | $5.1M | 443k | 11.61 | |
| Amarin Corp Adr | 0.3 | $5.1M | 1.2M | 4.38 | |
| TCR2 Therapeutics Comm | 0.3 | $4.9M | 296k | 16.41 | |
| Celldex Therapeutics Comm (CLDX) | 0.3 | $4.5M | 135k | 33.44 | |
| Mirum Pharmaceuticals Comm (MIRM) | 0.3 | $4.5M | 260k | 17.29 | |
| Jounce Therapeutics Comm | 0.2 | $4.2M | 625k | 6.80 | |
| Fate Therapeutics Comm (FATE) | 0.2 | $4.0M | 46k | 86.79 | |
| Aligos Therapeutics Comm | 0.2 | $3.3M | 164k | 20.38 | |
| ChemoCentryx Comm Call Option | 0.2 | $2.9M | 215k | 13.39 | |
| Otonomy Comm | 0.2 | $2.8M | 1.3M | 2.23 | |
| Replimune Group Comm (REPL) | 0.2 | $2.8M | 72k | 38.42 | |
| BioCryst Pharmaceuticals Comm (BCRX) | 0.1 | $2.5M | 159k | 15.81 | |
| ACADIA Pharmaceuticals Comm Call Option | 0.1 | $2.4M | 100k | 24.39 | |
| TCR2 Therapeutics Comm Put Option | 0.1 | $2.3M | 140k | 16.41 | |
| Synlogic Comm | 0.1 | $2.2M | 575k | 3.89 | |
| Savara Comm (SVRA) | 0.1 | $2.2M | 1.3M | 1.70 | |
| PDS Biotechnology Corporation Comm (PDSB) | 0.1 | $1.8M | 143k | 12.55 | |
| CTI BioPharma Corp Comm | 0.0 | $429k | 172k | 2.50 | |
| Sierra Oncology Comm | 0.0 | $49k | 2.5k | 19.60 |